Explore how proteomics in biomarker discovery accelerates diagnostic assay development and improves clinical validation.

Design Therapeutics (NASDAQ:DSGN) outlined its near-term clinical priorities and key upcoming data readouts during a ...

The landscape of dementia diagnostics is undergoing a paradigm shift with the emergence of liquid biopsy, blood-based biomarkers (BBMs), and blood-derived ...

Given the success of the previous collection, <a href=" Biomarkers of Cardiometabolic Disease, and the new advances in the field, we are pleased to announce the launch of Volume II.

TEM advances precision oncology as studies validate IPS, PurIST and xF+ diagnostics, highlighting stronger guidance for cancer therapy and biomarker detection.

Understand the importance of targeted assays in personalised medicine and how early decisions shape clinical outcomes.

Chronic hepatitis B is a viral disease that affects the liver and greatly increases the risks of liver cirrhosis and ...

Detailed price information for Alx Oncology Holdings Inc (ALXO-Q) from The Globe and Mail including charting and trades.

Discover why biomarkers are critical in modern drug discovery and clinical trials, enabling better target validation.

Researchers compared total plasma pTau217 with a brain-derived pTau217 assay to determine which better identifies Alzheimer’s disease–related amyloid and tau pathology. Brain-derived pTau217 showed ...